STAT3 and hepatocellular carcinoma: ICT effectively reduces the tumor weight and volume and prolongs survival in an HCC cell-bearing in vivo SCID model by inhibiting SphK1 and IL-6/JAK/STAT3 (Zhao et al., 2015; Lu et al., 2017).